Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | HH2853 |
Synonyms | |
Therapy Description |
HH2853 inhibits EZH1 and EZH2, potentially resulting in decreased tumor growth (Cancer Res (2023) 83 (8_Supplement): CT105). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
HH2853 | HH-2853|HH 2853 | EZH1 inhibitor 5 EZH2 inhibitor 20 | HH2853 inhibits EZH1 and EZH2, potentially resulting in decreased tumor growth (Cancer Res (2023) 83 (8_Supplement): CT105). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04390737 | Phase I | HH2853 | A Phase I Study to Evaluate the Safety and Clinical Activity of HH2853. | Recruiting | USA | 1 |